Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huangshi Xiangsheng pediatric throat spray for acute pharyngitis/tonsillitis
CTR20222888Phase 2Completed
- Sponsor
- Wuxi Jiyu Shanhe Pharmaceutical Technology
- Start
- Dec 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Huangshi Xiangsheng Spray in acute pharyngitis, acute tonsillitis, sponsored by Wuxi Jiyu Shanhe Pharmaceutical Technology. Started Dec 2022; status: completed.
02
Drugs
Huangshi Xiangsheng Spray
03
Conditions
acute pharyngitisacute tonsillitis
Beyond the preview
Go deeper on CTR20222888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222888.